Blb&B Advisors, LLC Neuronetics, Inc. Transaction History

Blb&B Advisors, LLC

$1.95 Billion
Q3 2024

A detailed history of Blb&B Advisors, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Blb&B Advisors, LLC holds 14,000 shares of STIM stock, worth $19,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,000

Holding current value

$19,460

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 22, 2024	BUY	$0.73 - $2.0 $10,220 - $28,000	14,000 New	14,000 $10,000
Q2 2023 Jul 20, 2023	BUY	$2.07 - $2.92 $61,969 - $87,416	29,937 New	29,937 $64,000

Others Institutions Holding STIM

# of Institutions

Shares Held

13.1M

Call Options Held

30.1K

Put Options Held

Kent Lake Pr LLC Anasco, PR

2.08M
Shares

$2.89 Million
0.63% of portfolio
Kent Lake Capital LLC Mill Valley, CA

1.74M
Shares

$2.42 Million
1.44% of portfolio
Cannell Capital LLC Alta, WY

1.31M
Shares

$1.83 Million
0.23% of portfolio
Vanguard Group Inc Valley Forge, PA

1.3M
Shares

$1.81 Million
0.0% of portfolio
Masters Capital Management LLC Atlanta, GA

1.2M
Shares

$1.67 Million
0.05% of portfolio

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $37.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Account